|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.39 USD | +4.41% |
|
+1.40% | +3.40% |
| 04-07 | Supernus Pharmaceuticals Inc enters asset purchase agreement with Navitor on April 1, 2026 | RE |
| 04-07 | Supernus Pharmaceuticals Enters Asset Purchase Agreement With Navitor Pharmaceuticals | MT |
| Capitalization | 2.96B 2.51B 2.31B 2.18B 4.05B 274B 4.12B 27.01B 10.59B 133B 11.1B 10.87B 468B | P/E ratio 2026 * |
91x | P/E ratio 2027 * | 166x |
|---|---|---|---|---|---|
| Enterprise value | 2.96B 2.51B 2.31B 2.18B 4.05B 274B 4.12B 27.01B 10.59B 133B 11.1B 10.87B 468B | EV / Sales 2026 * |
3.42x | EV / Sales 2027 * | 2.87x |
| Free-Float |
94.99% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supernus Pharmaceuticals, Inc.
| 1 day | +4.41% | ||
| 1 week | +1.40% | ||
| Current month | -0.58% | ||
| 1 month | +1.12% | ||
| 3 months | +2.78% | ||
| 6 months | +2.43% | ||
| Current year | +3.40% |
| 1 week | 48.35 |  | 52.31 |
| 1 month | 46.83 | | 52.69 |
| Current year | 46.83 | | 59.68 |
| 1 year | 29.16 | | 59.68 |
| 3 years | 21.99 | | 59.68 |
| 5 years | 21.99 | | 59.68 |
| 10 years | 13.12 | | 61.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jack Khattar
CEO | Chief Executive Officer | 64 | 2005-12-21 |
Timothy Dec
DFI | Director of Finance/CFO | 67 | 2021-08-22 |
| Compliance Officer | 63 | 2011-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 65 | 2015-03-22 |
Charles Newhall
CHM | Chairman | 80 | 2016-08-09 |
Frederick Hudson
BRD | Director/Board Member | 80 | 2010-11-15 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.41% | +1.40% | +67.07% | +39.84% | 2.96B | |
| +2.91% | +5.95% | +1.59% | -28.18% | 60.82B | |
| -2.24% | -3.88% | +12.42% | -20.31% | 8.17B | |
| +3.98% | +2.17% | +17.86% | +92.47% | 8.21B | |
| -0.85% | +7.11% | +1.44% | +44.13% | 5.66B | |
| -0.20% | +4.95% | -15.00% | +76.20% | 4.96B | |
| -2.26% | -0.41% | -13.89% | -37.73% | 2.72B | |
| -0.91% | -1.55% | +29.60% | +28.93% | 2.43B | |
| -2.31% | +1.48% | +91.21% | -1.65% | 2.01B | |
| -1.11% | -5.67% | -2.97% | -31.40% | 1.93B | |
| Average | +0.14% | +1.52% | +18.93% | +16.23% | 9.99B | |
| Weighted average by Cap. | +1.84% | +4.09% | +6.89% | -4.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 865M 733M 674M 638M 1.18B 80.03B 1.2B 7.89B 3.1B 38.79B 3.24B 3.18B 137B | 1.03B 873M 803M 760M 1.41B 95.37B 1.43B 9.41B 3.69B 46.23B 3.87B 3.79B 163B |
| Net income | 31.13M 26.37M 24.26M 22.96M 42.56M 2.88B 43.31M 284M 111M 1.4B 117M 114M 4.92B | 100M 84.97M 78.18M 73.99M 137M 9.28B 140M 916M 359M 4.5B 376M 368M 15.86B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-17 | 51.39 $ | +4.41% | 797,784 |
| 26-04-16 | 49.22 $ | -1.44% | 494,499 |
| 26-04-15 | 49.94 $ | -0.34% | 349,023 |
| 26-04-14 | 50.11 $ | +0.32% | 460,025 |
| 26-04-13 | 49.95 $ | -1.44% | 347,444 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SUPN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition